Tech Company Acquirers
Scintilla Pharmaceuticals
Wondering who was bought by Scintilla Pharmaceuticals? Semnur Pharmaceuticals was acquired by this biopharmaceutical company.
Company Overview
Company Name
Scintilla Pharmaceuticals
Company Status
Private & Independent
Industry
Biopharmaceutical
Acquisitions
Contact Information
Company Background Information
Overview
Scintilla Pharmaceuticals, Inc. is a subsidiary of Sorrento Therapeutics, Inc. Scintilla's lead program is RTX for the treatment of opiate refractory cancer pain. The RTX program has been tested successfully in a Phase 1 - 2 clinical trial, and is scheduled to commence Phase 2 clinical trials in early 2017.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/18/2016
Acquisitions By Scintilla Pharmaceuticals
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Henry Ji
Browse more tech company acquirers:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs